PAHC PHIBRO ANIMAL HEALTH CORP
FY2025 10-K
PHIBRO ANIMAL HEALTH CORP (PAHC) filed its fiscal year 2025 10-K annual report with the SEC on Aug 27, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business model: Global animal health and mineral nutrition solutions for livestock and companion animals, marketing ~800 product lines across 90 countries
- • New acquisition: Zoetis medicated feed additive portfolio acquired for $297.5M, adding $208.2M net sales in FY25 and 6 manufacturing sites in US, Italy, China
Management Discussion & Analysis
- • Revenue $1.296B, up 27% YoY from $1.018B; Animal Health best segment $963M, up 36% YoY; Performance Products worst $80.2M, up 19%
- • Adjusted net income $84.9M, up 76% YoY from $48.4M; adjusted diluted EPS $2.09 vs $1.19 prior year
Risk Factors
- • Cybersecurity attacks increasing in sophistication, with potential for material business impact
- • AI technology adoption risks, including compliance with privacy regulations and ethical use across enterprise
Get deeper insights on PHIBRO ANIMAL HEALTH CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.